The grant will fund research conducted by Dr. Adam Hacking, PhD, to improve treatment methods for infections associated with implanted devices. The NIH’s National Institute of Arthritis and Musculoskeletal and Skin Disease provided the funding.
Dr. Hacking is the chief scientific officer for OPM, which produces devices for artificial hips, knees and other implantables with the advanced applications of three-dimensional printing of PEKK.
Since device-related infections can result in prolonged patient suffering and expected costs of $12 billion next year, there is a huge opportunity in this area.
More articles on orthopedic devices:
Orthofix financial report saga: Deadlines extended to January 2015, trading continues
Alphatec Spine to attend 2 investor conferences in December
Is Stryker’s move for Smith & Nephew imminent? 10 things to know
